Short-term cell availability and distribution of intramyocardial engrafted mesenchymal stem cells in normal and chronic infarcted myocardium

LI Yan

DOI: https://doi.org/10.3969/j.issn.1005-8982.2007.23.001

2007-01-01

Abstract:[Objective] To investigate the short-term cell availability and cell distribution of 111Indium-oxine labeled bone marrow mesenchymal stem cells (BMSCs) intramyocardial transplanted in the normal and chronic infarcted myocardium. [Methods] Myocardial infarction was created in the rats model (n =9) with selective coronary artery ligation. One month later, 111Indium-oxine labeled autologous BMSCs (2×106 cells in 50 μL) were injected into the chronic infarcted myocardium and the normal control (n =6). Cardiac specific radioactivity was assessed by serial planar pinhole scintigraphy at 2 hour, 1, 3, and 7 days after BMSCs transplantation, cell retention rate in myocardium was calculated. Cell distribution in myocardium was observed by micro-imaging of myocardial tissue specific radioactivity and histo-pathological analysis, performed on the transverse cryosections of the hearts harvested at 7th day. [Results] The cardiac uptake of 111Indium in MI group was significantly (P <0.01) higher than the control group at each time-point. When measured cardiac specific radioactivity was corrected according to the spontaneous leakage rates of 111Indium from labeled BMSCs, the myocardial retention of BMSCs determined in vitro at each corresponding time-point was about 60% in chronic infarcted myocardium, but only 25% when cells were injected into the normal myocardium (P <0.01), and these values were consistent during 7 days follow-up period. Micro-imaging and histo-pathological analysis confirmed that transplanted BMSCs located predominantly in the fibrosis zones created by needle insertion or chronic myocardial infarction. [Conclusions] Intramyocardial engrafted BMSCs predominantly locate in the fibrous scar tissue of myocardium damaged by needle insertion or chronic myocardial infarction, and the cell availability is higher when they are implanted into the chronic infarcted myocardium than they are engrafted into the normal myocardium, at least for 7 days after cell transplantation.